We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is not prepared to accept all of the recommendations put forth by the Heart Rhythm Society (HRS) on tracking pacemakers and implantable cardioverter-defibrillators (ICDs) for potential malfunctions.
Inovio Biomedical Corporation announced today that it has acquired, under a license with Sphergen SARL, rights to several patent families relating to the use of electroporation technology.
Cepheid, a broad-based molecular diagnostics company, today announced the European release of the Smart EBV (Epstein-Barr Virus) Assay for clinical diagnostic use on the SmartCycler System.
Acrux, the pharmaceutical company with unique technology for delivering drugs through the skin, today announced positive results in a US Phase 3 clinical trial of Evamist, its daily skin spray for prevention of symptoms associated with menopause.
A new high-technology medical device used with MRI scanners that helps doctors watch the beating heart has been approved by the U.S. Food and Drug Administration.
Some Guidant defibrillators may suddenly stop working, jeopardizing the lives of heart-failure patients, Boston Scientific said in a warning letter to physicians dated May 12.